Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 1217 results found. Search for [ efficacy ]

Results 1 to 21 of 1217
Reuters
May 7, 2021
A WHO emergency listing is a signal to national regulators on a product's safety and efficacy, and would allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries


BusinessToday.In
May 7, 2021
Multiple studies have been conducted on AYUSH-64, an Ayurvedic formulation developed by the Central Council for Research in Ayurvedic Sciences (CCRAS), and Kabasura Kudineer, a classical Siddha formulation


BusinessToday.In
New Delhi, May 7, 2021
State-run lenders will take a lead in creation of the bad bank, but the sick asset resolution platform needs the support of private banks and other lenders to be successful, said State Bank of India Managing Director Swaminathan; India has welcomed the US support for a relaxation in the norms of the TRIPS (Trade-Related Aspects of Intellectual Property Rights) agreement to ensure quick and affordable access to Covid-19 vaccines and medicines for developing countries; Jindal Steel and Power Ltd (JSPL) said it has ramped up its daily oxygen supply limit to 120 tonne/day for the treatment of COVID-19 patients. Watch this and more news on News Blast.Also Read: Covid second wave to have muted impact on economy: Finance Ministry


PTI
May 7, 2021
In a letter to Prime Minister Narendra Modi, he suggested that the government should not be concerned about the economic impact of the lockdown as the human cost of the spread of of the virus would have tragic consequences for the people


Rashi Bisaria
New Delhi, May 7, 2021
COVID-19 in India: Centre issues guidelines for vaccination of aviation staffThe Centre on Thursday, issued an advisory to facilitate swift COVID-19 vaccination of aviation personnel working in government as well as private entities. As per the guidelines, civil aviation community provided unhindered services for the movement of people in need and essential cargo including critical medical cargo like vaccines, medicines, Oxygen Concentrators, etc., thus their vaccination remains a priority....


Vivek Dubey
May 6, 2021
\"The cost of the Sputnik Light vaccine globally will be less than $10 [around Rs 730], while it has simple storage requirements, at 2-8 degrees Celsius, which provide for easy logistics\"


Reuters
May 4, 2021
Pfizer said it is holding fresh talks with the government after having withdrawn its initial application in February over the earlier local trial rule


Reuters
April 30, 2021
This is the first time the Anglo-Swedish drugmaker has given financial details of the distribution and sales of its vaccine, which it developed with Oxford University


Anand Adhikari
April 29, 2021
There are over a dozen ARCs in the private sector, though only 3-4 dominate the bad loan resolution business; more freedom and flexibility is needed to strengthen them


BusinessToday.In
April 28, 2021
The committee will review existing legal and regulatory framework applicable to ARCs and recommend measures to improve their efficacy. It'll also review the role of ARCs in resolution of stressed assets, including under IBC


BusinessToday.In
April 28, 2021
\"Initial positive neutralisation studies of B.1.617, with both post-Covaxin or Covishield sera, are correlatable with milder disease during post-vaccination breakthrough infections,\" says Anurag Agrawal, Director, Institute of Genomics and Integrative Biology


PTI
April 28, 2021
Developed by Bharat Biotech in partnership with National Institute of Virology and the Indian Council of Medical Research, Covaxin was approved for emergency use on January 3


Joe C Mathew
April 26, 2021
The Parliamentary Standing Committee on Health and Family Welfare had asked the central government to encourage adequate production of oxygen for ensuring its supply as per demand in hospitals.


BusinessToday.In
April 25, 2021
The Hyderabad-based vaccine manufacturer has submitted updated accelerated and real-time stability data of Coaxin along with the justification for the extension of shelf life


BusinessToday.In
April 24, 2021
At these rates, Covaxin will be twice as costly as Covishield, which will be sold to state governments at Rs 400 per dose and to private hospitals at Rs 600 per dose in Phase 3 of vacccination drive


BusinessToday.In
April 24, 2021
Fauci added that India needed the COVID-19 vaccines although variants of the coronavirus have developed in the country and that efficacy of the vaccines against these variants needs to be studied


BusinessToday.In
April 23, 2021
Zydus Cadila stated that 91.15 per cent of patients who were treated with the antiviral Virafin were RT-PCR negative by Day 7. The treatment also reduces hours of supplemental oxygen in patients


BusinessToday.In
New Delhi, April 22, 2021
Adar Poonawalla, CEO, Serum Institute of India, explains the impact of the Covishield vaccine on the double mutant strain present in India. In an exclusive conversation with India Today, Poonawalla said that the COVID vaccines were initially developed with an idea to reduce the death numbers, keep people away from getting hospitalised and lower the burden on doctors. He added that Covishield has displayed 90% efficacy against all coronavirus variants, keeping people away from the need for oxygen and ventilators. On the other hand, the healthcare sector is going through an acute shortage of beds, ventilators and oxygen in India. Watch the video for more details. Also Read: COVID-19: Pfizer to supply coronavirus vaccine at 'not-for-profit' rate to Centre


PB Jayakumar
April 22, 2021
Mumbai headquartered pharma and nutraceutical specialty ingredient maker VAV Lifesciences and its subsidiary VAV Lipids is going to supply highly purified 'synthetic phospholipids' required for vaccine manufacturing in US


BusinessToday.In
New Delhi, April 22, 2021
Bharat Biotech's COVID-19 vaccine has shown an overall interim clinical efficacy of 78 per cent and 100 per cent efficacy against severe COVID-19 disease; Putting tremendous pressure on the nation's medical infrastructure, the latest surge in COVID-19 cases has driven up the demand for medical oxygen, a critical commodity in treating the respiratory ailment; At the current pace of vaccination against coronavirus, India would need another 8 years and 9 months to inoculate 70 per cent of its entire population, a threshold required to achieve herd immunity. Watch this and more news on News Blast. Read | COVID-19: Tips from psychologists to cope in these uncertain timesAlso Read | AUMs of Indian Mutual Fund industry decreases 0.5% m-o-m


PAGES 1 OF 61  12345